Efficient Vaccine Consultations to Reduce Influenza’s Impact in Older Adults

Released On
September 6, 2018

Expires On
September 6, 2019

Media Type
Internet

Completion Time
60 minutes

Specialty
Physicians, Nurses

Topic(s)
Influenza's Impact

Scroll to the Bottom of this Information to Begin this Course

This activity is sponsored by The Academy for Continued Healthcare Learning (ACHL)
This program has been developed in collaboration with The Gerontological Society of America.


This activity is supported by an educational grant from Seqirus.

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)
  • Nurses — 1.25 contact hours.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for United States based Physicians and Nurses.

Program Overview

This activity explores how to actively approach older patients to discuss influenza vaccine options. The goal is to reduce the older patient’s risk of influenza and its associated morbidity and mortality.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the impact of influenza on older populations
  • Review influenza vaccine options for older patients
  • Identify the steps required to improve influenza vaccine uptake in older patients
  • Apply a structured approach to offering, recommending, and immunizing individuals with the influenza vaccine
  • Manage common patient issues linked with declining influenza vaccination

Faculty

Planning Committee

  • Stefan Gravenstein, MD, MPH
  • Donald B. Middleton, MD
  • Barbara Resnick, PhD, RN, CRNP
  • William A. Fisher, PhD, FCAHS

Expert Video Commentary

  • Stefan Gravenstein, MD, MPH

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and mdBriefCase. ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number 14803 for 1.25 contact hour.

Disclosure Information

Academy for Continued Healthcare Learning (ACHL) staff members, mdBriefCase staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Mitigation Potential Bias

  • The content has been developed based on needs assessment results
  • The 4 planning committee members developed the program content independent of the sponsor to include equal coverage of relevant therapies. The content was also reviewed by an independent peer reviewer.

Disclosures of Conflicts of Interest

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Stefan Gravenstein, MD, MPH

  • Advisory Board: Seqirus, Sanofi
  • Speakers Bureau/Honoraria: Pfizer, Seqirus, Sanofi
  • Other: Longevoron (Chair DSMB), Merck (Member, SRC)
  • Potential for conflict(s) of interest: have received payment/funding from the sponsor(s) supporting this program and/or organization whose product(s) are being discussed in this program
  • Mitigating Potential Bias: This has been mitigated by an independent peer reviewer.

Donald Middleton, MD

  • Advisory Board: Merck, Pfizer, Sanofi Pasteur, GlaxoSmithKline
  • Potential for conflict(s) of interest: have not received payment/funding from the sponsor(s) supporting this program and/or organization whose product(s) are being discussed in this program
  • Mitigating Potential Bias: This has been mitigated by an independent peer reviewer.

Barbara Resnick, PhD, RN, CRNP

  • Potential for conflict(s) of interest: have not received payment/funding from the sponsor(s) supporting this program and/or organization whose product(s) are being discussed in this program
  • Mitigating Potential Bias: This has been mitigated by an independent peer reviewer.

William A. Fisher, PhD, FCAHS

  • Grants/Research Support: Seqirus
  • Speakers Bureau/Honoraria: Merck
  • Consulting Fees: mdBriefCase, Ascensia, Valeant
  • Potential for conflict(s) of interest: have received payment/funding from the sponsor(s) supporting this program and/or organization whose product(s) are being discussed in this program
  • Mitigating Potential Bias: This has been mitigated by an independent peer reviewer.

Instructions for Participation and Credit

To receive credit, participants are required to complete the pre-test, view the activity, and complete the post-activity evaluation and post-test. To receive credit, 70% must be achieved on the post-test. Upon completion, participants will receive an automated certificate. You may print or save this record for your files.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclaimer

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.